| P2093 | author name string | Mariana J Kaplan | |
| | James D Myles | |
| | Robert Brook | |
| | Rita Hench | |
| | Shokoufeh Khalatbari | |
| | Srilakshmi Yalavarthi | |
| | Susan Lustig | |
| | Wendy Marder | |
| P2860 | cites work | Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study | Q24812262 |
| | Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 |
| | The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 |
| | Inhalation of fine particulate air pollution and ozone causes acute arterial vasoconstriction in healthy adults | Q29615466 |
| | EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis | Q33505914 |
| | Inflammation and microvascular and macrovascular endothelial dysfunction in rheumatoid arthritis: effect of treatment | Q33531382 |
| | Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction | Q33642021 |
| | Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis | Q33686973 |
| | Autoantibodies and the risk of cardiovascular events | Q33721605 |
| | Relation of brachial and digital measures of vascular function in the community: the Framingham heart study | Q33801973 |
| | Ultrasound assessment of flow-mediated dilation | Q33886009 |
| | Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients | Q33947313 |
| | Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells | Q33967700 |
| | Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. | Q33967744 |
| | Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis | Q34283776 |
| | Determinants of vascular function in patients with chronic gout | Q34788956 |
| | Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies | Q34889152 |
| | Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity | Q35553196 |
| | A polymorphism in the interleukin-4 receptor affects the ability of interleukin-4 to regulate Th17 cells: a possible immunoregulatory mechanism for genetic control of the severity of rheumatoid arthritis | Q35620302 |
| | Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy | Q35676074 |
| | Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register | Q36732112 |
| | Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-kappaB and C/EBPbeta activation | Q37283121 |
| | A controlled comparison of brachial artery flow mediated dilation (FMD) and digital pulse amplitude tonometry (PAT) in the assessment of endothelial function in systemic lupus erythematosus | Q37369357 |
| | Management of cardiovascular disease risk in chronic inflammatory disorders | Q37428743 |
| | Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. | Q37583248 |
| | The widening mortality gap between rheumatoid arthritis patients and the general population | Q38459919 |
| | Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force | Q39605814 |
| | Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice | Q43455128 |
| | Rheumatoid arthritis and mortality. A longitudinal study in Pima Indians. | Q43616578 |
| | Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. | Q44068950 |
| | Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis | Q44177928 |
| | Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis | Q44453472 |
| | Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis | Q44706286 |
| | IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenol-induced heart failure. | Q45968562 |
| | Auto-antibodies do not influence development of atherosclerotic plaques in rheumatoid arthritis. | Q46610997 |
| | Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. | Q46802505 |
| | Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis | Q48502988 |
| | Cardiovascular risk stratification in older patients: role of brain natriuretic peptide, C-reactive protein, and urinary albumin levels | Q48942108 |
| | Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. | Q50701881 |
| | Arterial stiffness in a muscular artery in women with longstanding rheumatoid arthritis compared with healthy controls and patients with traditional cardiovascular risk factors. | Q51610024 |
| | Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity. | Q52094951 |
| | [Tobacco dependence: first risk factor of atherosclerosis. Survey among smokers and non-smokers in group dynamics] | Q52267394 |
| | Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice. | Q52595013 |
| | Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques. | Q54449577 |
| | Brachial Artery Vasodilator Function and Systemic Inflammation in the Framingham Offspring Study | Q57073132 |
| | Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study | Q60298067 |
| | High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors | Q77406810 |
| | Long-term morbidity, mortality, and economics of rheumatoid arthritis | Q77406814 |
| | Noninvasive detection of atherosclerosis | Q77738559 |
| | Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years | Q78794833 |
| | Screening for atherosclerosis in patients with rheumatoid arthritis: comparison of two in vivo tests of vascular function | Q78794847 |
| | Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease | Q79354392 |
| | Sustained improvement of vascular endothelial function during anti-TNFalpha treatment in rheumatoid arthritis patients | Q79808209 |
| | Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy | Q80213278 |
| | Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis | Q81070646 |
| | Th1/Th17 cytokine profiles in patients with reactive arthritis/undifferentiated spondyloarthropathy | Q81442977 |
| | Cardiovascular death in rheumatoid arthritis: a population-based study | Q81484761 |
| | Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis | Q81922641 |
| | Mechanisms of endothelial cell heterogeneity in health and disease | Q82459526 |
| | Myeloperoxidase (MPO) and interleukin-17 (IL-17) plasma levels are increased in patients with acute coronary syndromes | Q84201343 |
| | Role of Th17 cells in human autoimmune arthritis | Q84488292 |
| | Association between IL-17F gene polymorphisms and susceptibility to and severity of rheumatoid arthritis (RA) | Q84553425 |
| | Association between arterial stiffness and atherosclerosis: the Rotterdam Study | Q95751064 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 1550-1555 | |
| P577 | publication date | 2011-07-04 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritis | |
| P478 | volume | 70 | |